ELAN CORP has a total of 17 patent applications. Its first patent ever was published in 1987. It filed its patents most often in Ireland, Czechoslovakia and Czechia. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are Arven Ilac Sanayi Ve Ticaret Anonim Sirketi, SUNOVION RESPIRATORY DEV INC and WUHAN HOSPITAL OF TRADITIONAL CHINESE MEDICINE.
# | Country | Total Patents | |
---|---|---|---|
#1 | Ireland | 8 | |
#2 | Czechoslovakia | 2 | |
#3 | Czechia | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Hungary | 1 | |
#6 | Israel | 1 | |
#7 | Philippines | 1 | |
#8 | Poland | 1 | |
#9 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines | |
#4 | Medical technology | |
#5 | Organic fine chemistry | |
#6 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Steroids | |
#4 | Unspecified technologies | |
#5 | Unspecified technologies | |
#6 | Syringes | |
#7 | Cocoa and sweets | |
#8 | Microorganisms | |
#9 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Myers Michael | 4 |
#2 | Mulligan Seamus | 3 |
#3 | Tsals Izrail | 3 |
#4 | Clancy Maurice Joseph Anthony | 3 |
#5 | Lavi Gilad | 3 |
#6 | Gross Joseph | 3 |
#7 | Cumming Kenneth Iain | 3 |
#8 | Sparks Randall T | 3 |
#9 | Masterson Joseph Gerard | 1 |
#10 | Geoghegan Edward J | 1 |
Publication | Filing date | Title |
---|---|---|
EP1230267A2 | Membrane translocating peptide drug delivery system | |
IE980211A1 | Improved Drug Delivery Device | |
IE970782A1 | An improved automatic syringe | |
IE970444A1 | Improved drug delivery kit and method of packaging the same | |
IE970131A1 | Improved iontophoretic drug delivery device and method of manufacturing the same | |
IES930594A2 | Combined drug delivery system | |
IE900306A1 | Agent for use in the prevention, control or reversal of¹hypertension | |
IE892257A1 | Anti-infective agent, process for its preparation and its¹use in therapy | |
IE870064L | Sustained release capsule or tablet formulation |